HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huyen Cao Selected Research

remdesivir

1/2022Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
11/2021A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
11/2021Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
1/2021Reply to Yan and Muller, "Remdesivir for COVID-19: Why Not Dose Higher?"
1/2021Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor.
1/2021Compassionate Use of Remdesivir in Children With Severe COVID-19.
11/2020Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
11/2020Compassionate Use of Remdesivir for Patients with Severe Covid-19.
1/2020Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
1/2020Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Huyen Cao Research Topics

Disease

13Infections
11/2021 - 01/2005
10COVID-19
01/2022 - 01/2020
9HIV Infections (HIV Infection)
08/2014 - 08/2004
2Nausea
11/2020 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 02/2016
2Proteinuria
08/2015 - 06/2015
2Pulmonary Tuberculosis
01/2012 - 03/2010
2Tuberculosis (Tuberculoses)
01/2012 - 03/2010
2Anthrax
02/2011 - 01/2002
2Disease Progression
11/2010 - 04/2005
2Acquired Immunodeficiency Syndrome (AIDS)
06/2010 - 07/2007
2Coinfection
04/2005 - 02/2004
1Pneumonia (Pneumonitis)
11/2021
1Severe Acute Respiratory Syndrome
01/2021
1Constipation
11/2020
1Respiratory Insufficiency (Respiratory Failure)
11/2020
1Hypertension (High Blood Pressure)
01/2020
1Hypokalemia
01/2020
1Headache (Headaches)
01/2020
1Ebola Hemorrhagic Fever
12/2019
1Carotid Artery Diseases
02/2016
1Renal Insufficiency (Renal Failure)
06/2015
1Neoplasms (Cancer)
06/2014
1Cough
01/2012
1Malaria
05/2008
1Hypersensitivity (Allergy)
10/2007
1Communicable Diseases (Infectious Diseases)
10/2007
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2006
1Viremia
04/2005
1Mumps
08/2004
1Human Influenza (Influenza)
08/2004
1Schistosomiasis (Bilharziasis)
02/2004
1Virus Diseases (Viral Diseases)
03/2003

Drug/Important Bio-Agent (IBA)

10remdesivirIBA
01/2022 - 01/2020
5VaccinesIBA
02/2009 - 02/2004
4tenofovir alafenamideIBA
01/2017 - 06/2015
4Tenofovir (Viread)FDA Link
01/2017 - 06/2015
3AntigensIBA
01/2022 - 01/2002
3RNA (Ribonucleic Acid)IBA
11/2021 - 09/2011
3Antiviral Agents (Antivirals)IBA
11/2020 - 10/2006
3Emtricitabine (Emtriva)FDA Link
01/2017 - 06/2015
3Interleukin-10 (Interleukin 10)IBA
12/2009 - 04/2005
2bamlanivimabIBA
01/2022 - 11/2021
2Monoclonal AntibodiesIBA
01/2022 - 11/2021
2Oxygen (Dioxygen)IBA
11/2021 - 11/2020
2EnzymesIBA
01/2021 - 01/2012
2Rilpivirine (TMC-278)IBA
01/2017 - 01/2017
2Tryptophan (L-Tryptophan)FDA Link
02/2016 - 08/2014
2KynurenineIBA
02/2016 - 08/2014
2elvitegravirIBA
08/2015 - 06/2015
2Interferon-gamma (Interferon, gamma)IBA
01/2012 - 03/2010
2Peptides (Polypeptides)IBA
02/2011 - 01/2005
2Transforming Growth Factor beta (TGF-beta)IBA
03/2010 - 12/2009
2AIDS VaccinesIBA
02/2009 - 10/2007
1tocilizumab (atlizumab)FDA Link
11/2021
1GS-441524 triphosphateIBA
01/2021
1triphosphoric acid (triphosphate)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1NucleosidesIBA
01/2021
1Alanine Transaminase (SGPT)IBA
11/2020
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
11/2020
1efavirenz (Sustiva)FDA Link
01/2017
1Interleukin-6 (Interleukin 6)IBA
02/2016
1Lipopolysaccharide ReceptorsIBA
02/2016
1ProdrugsIBA
08/2015
1Protease Inhibitors (Protease Inhibitor)IBA
08/2015
1TabletsIBA
08/2015
1CreatinineIBA
06/2015
1CobicistatIBA
06/2015
1Interleukin-17 (Interleukin 17)IBA
08/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2014
1InterleukinsIBA
06/2014
1AcidsIBA
01/2012
1gag Gene Products (gag Protein)IBA
02/2011
1Anti-Infective Agents (Microbicides)IBA
06/2010
1Biomarkers (Surrogate Marker)IBA
02/2009
1AIDSVAXIBA
02/2009
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2008
1Antimalarials (Antimalarial Agents)IBA
01/2006
1CytokinesIBA
02/2004

Therapy/Procedure

7Therapeutics
12/2019 - 08/2004
1Artificial Respiration (Mechanical Ventilation)
11/2020
1Art Therapy
02/2011
1Highly Active Antiretroviral Therapy (HAART)
08/2004